Metabolite may hold key to new severe asthma therapies

Australian-led research shows patients with severe disease have lower levels of carnitine in their urine, says Dr Stacey Reinke from Edith Cowan University in Perth and fellow author
Australian Associated Press
Dr Stacey Reinke.

A key biochemical difference in people with severe asthma has been identified by an Australian-led research project which may lead to better treatment.

The team report the metabolite carnitine decreases in those with severe disease, independently of oral corticosteroid treatment.